(Q48846598)

16 February 2018

title

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. (English)

1 reference

16 February 2018

1 reference

1

1 reference

16 February 2018

Véronique Sgambato-Faure

8

object named as

Véronique Sgambato-Faure

1 reference

16 February 2018

author name string

Helene Klinger

2

1 reference

16 February 2018

Julien Eche

3

1 reference

16 February 2018

Jérôme Lerond

4

1 reference

16 February 2018

Anne-Evelyne Vallet

5

1 reference

16 February 2018

Didier Le Bars

6

1 reference

16 February 2018

Leon Tremblay

7

1 reference

16 February 2018

Emmanuel Broussolle

9

1 reference

16 February 2018

Stéphane Thobois

10

1 reference

16 February 2018

language of work or name

English

0 references

publication date

12 October 2011

1 reference

16 February 2018

published in

Movement Disorders

1 reference

16 February 2018

volume

27

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

84-89

1 reference

16 February 2018

Neuropsychiatric symptoms in Parkinson's disease

cites work

1 reference

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.

21 January 2018

1 reference

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

21 January 2018

1 reference

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.

21 January 2018

1 reference

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom

21 January 2018

1 reference

Monoamine transporter availability in Parkinson's disease patients with or without depression

21 January 2018

1 reference

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

21 January 2018

1 reference

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia

21 January 2018

1 reference

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

21 January 2018

1 reference

Spared caudal brainstem SERT binding in early Parkinson's disease

21 January 2018

1 reference

Positron emission tomography of striatal serotonin transporters in Parkinson disease

21 January 2018

1 reference

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease

21 January 2018

1 reference

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

21 January 2018

1 reference

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

21 January 2018

1 reference

The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease

21 January 2018

1 reference

Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

21 January 2018

1 reference

Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.

21 January 2018

1 reference

Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography

21 January 2018

1 reference

Regional patterns of brain tissue loss associated with depression in Parkinson disease.

21 January 2018

1 reference

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.

21 January 2018

1 reference

Minor depression and brain perfusion images in Parkinson's disease.

21 January 2018

1 reference

Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus

21 January 2018

1 reference

Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics.

21 January 2018

1 reference

Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition

21 January 2018

1 reference

Serotonin and Parkinson's disease: On movement, mood, and madness

21 January 2018

1 reference

5-HT(1A) receptor function in major depressive disorder

21 January 2018

1 reference

Sertraline for the treatment of depression in Parkinson's disease.

21 January 2018

1 reference

PET imaging of serotonin 1A receptor binding in depression

21 January 2018

1 reference

Serotonin 1A receptor binding and treatment response in late-life depression

21 January 2018

1 reference

Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study

21 January 2018

1 reference

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

21 January 2018

1 reference

Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys.

21 January 2018

1 reference

Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23895

1 reference

16 February 2018

PubMed ID

21994070

1 reference

16 February 2018